Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127596781 | 12759678 | 1 | I | 2007 | 20120622 | 20160919 | 20160919 | PER | US-ASTRAZENECA-2012BM10134 | ASTRAZENECA | 66.28 | YR | A | F | Y | 94.30000 | KG | 20160919 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127596781 | 12759678 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | Y | U | A923105C | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | ||||
127596781 | 12759678 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | Y | U | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||
127596781 | 12759678 | 3 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | Y | U | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||
127596781 | 12759678 | 4 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | Y | U | A923105C | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | ||||
127596781 | 12759678 | 5 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | UNK | Y | U | 21773 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | |||||||
127596781 | 12759678 | 6 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | Y | U | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||
127596781 | 12759678 | 7 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | Y | U | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||
127596781 | 12759678 | 8 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | Y | U | A923105C | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | ||||
127596781 | 12759678 | 9 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | 5 MCG SQ TWICE A DAY STARTING 10 TO 12 YEARS AGO | Y | U | 21773 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | |||||||
127596781 | 12759678 | 10 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | Y | U | 21773 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | ||||||||
127596781 | 12759678 | 11 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 0 | 2 | MG | /wk | ||||||||
127596781 | 12759678 | 12 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 0 | 2 | MG | /wk | ||||||||
127596781 | 12759678 | 13 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG, BID | 0 | 1000 | MG | BID | |||||||
127596781 | 12759678 | 14 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG, BID | 0 | 1000 | MG | BID | |||||||
127596781 | 12759678 | 15 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 500 | MG | QD | ||||||||
127596781 | 12759678 | 16 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 500 | MG | QD | ||||||||
127596781 | 12759678 | 17 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 500 | MG | BID | ||||||||
127596781 | 12759678 | 18 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 500 | MG | BID | ||||||||
127596781 | 12759678 | 19 | C | FIBER | PSYLLIUM HUSK | 1 | UNK | 0 | |||||||||||
127596781 | 12759678 | 20 | C | PEPCID | FAMOTIDINE | 1 | 0 | ||||||||||||
127596781 | 12759678 | 21 | C | IMODIUM AD | LOPERAMIDE HYDROCHLORIDE | 1 | 0 | ||||||||||||
127596781 | 12759678 | 22 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
127596781 | 12759678 | 23 | C | SUDOGEST | PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
127596781 | 12759678 | 24 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | 0 | ||||||||||||
127596781 | 12759678 | 25 | C | ALLERGY SHOTS | UNSPECIFIED INGREDIENT | 1 | 0 | ||||||||||||
127596781 | 12759678 | 26 | C | PRESCRIPTION EYE DROPS | 2 | 0 | |||||||||||||
127596781 | 12759678 | 27 | C | PRESCRIPTION NOSE DROPS | 2 | 0 | |||||||||||||
127596781 | 12759678 | 28 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 | ||||||||||||
127596781 | 12759678 | 29 | C | STRATTERA | ATOMOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
127596781 | 12759678 | 30 | C | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | 0 | ||||||||||||
127596781 | 12759678 | 31 | C | TRICOR | FENOFIBRATE | 1 | 0 | ||||||||||||
127596781 | 12759678 | 32 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127596781 | 12759678 | 1 | Type 2 diabetes mellitus |
127596781 | 12759678 | 2 | Type 2 diabetes mellitus |
127596781 | 12759678 | 3 | Type 2 diabetes mellitus |
127596781 | 12759678 | 4 | Type 2 diabetes mellitus |
127596781 | 12759678 | 5 | Type 2 diabetes mellitus |
127596781 | 12759678 | 6 | Type 2 diabetes mellitus |
127596781 | 12759678 | 7 | Type 2 diabetes mellitus |
127596781 | 12759678 | 8 | Type 2 diabetes mellitus |
127596781 | 12759678 | 9 | Type 2 diabetes mellitus |
127596781 | 12759678 | 10 | Type 2 diabetes mellitus |
127596781 | 12759678 | 11 | Type 2 diabetes mellitus |
127596781 | 12759678 | 12 | Type 2 diabetes mellitus |
127596781 | 12759678 | 13 | Type 2 diabetes mellitus |
127596781 | 12759678 | 14 | Diabetes mellitus |
127596781 | 12759678 | 15 | Type 2 diabetes mellitus |
127596781 | 12759678 | 16 | Diabetes mellitus |
127596781 | 12759678 | 17 | Type 2 diabetes mellitus |
127596781 | 12759678 | 18 | Diabetes mellitus |
127596781 | 12759678 | 20 | Nausea |
127596781 | 12759678 | 21 | Diarrhoea |
127596781 | 12759678 | 23 | Drug hypersensitivity |
127596781 | 12759678 | 25 | Drug hypersensitivity |
127596781 | 12759678 | 26 | Drug hypersensitivity |
127596781 | 12759678 | 27 | Drug hypersensitivity |
127596781 | 12759678 | 28 | Nervous system disorder |
127596781 | 12759678 | 29 | Attention deficit/hyperactivity disorder |
127596781 | 12759678 | 30 | Periodic limb movement disorder |
127596781 | 12759678 | 31 | Blood triglycerides |
127596781 | 12759678 | 32 | Hypothyroidism |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127596781 | 12759678 | Abdominal discomfort | |
127596781 | 12759678 | Blood glucose increased | |
127596781 | 12759678 | Diarrhoea | |
127596781 | 12759678 | Drug ineffective | |
127596781 | 12759678 | Dysgeusia | |
127596781 | 12759678 | Gastrooesophageal reflux disease | |
127596781 | 12759678 | Glycosylated haemoglobin increased | |
127596781 | 12759678 | Injection site bruising | |
127596781 | 12759678 | Injection site erythema | |
127596781 | 12759678 | Injection site pain | |
127596781 | 12759678 | Injection site pruritus | |
127596781 | 12759678 | Injection site swelling | |
127596781 | 12759678 | Nausea | |
127596781 | 12759678 | Periodic limb movement disorder | |
127596781 | 12759678 | Tendon injury | |
127596781 | 12759678 | Urine odour abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127596781 | 12759678 | 1 | 200706 | 200709 | 0 | |
127596781 | 12759678 | 2 | 200709 | 200909 | 0 | |
127596781 | 12759678 | 3 | 200809 | 0 | ||
127596781 | 12759678 | 4 | 201205 | 0 | ||
127596781 | 12759678 | 5 | 201206 | 0 | ||
127596781 | 12759678 | 7 | 20120913 | 20120916 | 0 | |
127596781 | 12759678 | 8 | 201206 | 20120912 | 0 | |
127596781 | 12759678 | 9 | 201607 | 201607 | 0 | |
127596781 | 12759678 | 12 | 201607 | 0 | ||
127596781 | 12759678 | 13 | 200906 | 0 | ||
127596781 | 12759678 | 14 | 200906 | 0 | ||
127596781 | 12759678 | 15 | 20120805 | 20120812 | 0 | |
127596781 | 12759678 | 16 | 20120805 | 20120812 | 0 | |
127596781 | 12759678 | 17 | 20120812 | 0 | ||
127596781 | 12759678 | 18 | 20120812 | 0 |